David is a Senior Advisor at Biospring Partners where he works closely with the investment team across the pharma services sector. He brings nearly 30 years of experience spanning healthcare operations, fundraising, and investing, and has served in governance roles across the ecosystem, including as a member of general partner (GP), limited partner (LP), limited partner advisory committee (LPAC), investment committee, and company Board structures.
Prior to joining Biospring, David was a Managing Director at Koch Disruptive Technologies, where he led the healthcare investment strategy across multiple subsectors, overseeing a substantial private investment portfolio. Earlier in his career, David held senior leadership roles at several healthcare firms and co-founded two healthcare investment firms. David holds a BA from Duke University and an MD from Geisel School of Medicine at Dartmouth.
